Leading provider of air decontamination technology develops retrofittable reactors for air conditioning systems in a modern production site in the Paris area
Paris, December 18, 2020. Calistair’s leading position in the fight against the corona virus and Covid-19 now brings the company a special grant: The Paris Ile-de-France region has received a grant of 310,000 to Calistair as part of the PM’up Covid-19 project call Euros awarded.
The extraordinary PM’up Covid-19 aid of the region is intended in particular to support medium-sized companies that implement projects to create, redesign or strengthen the production capacities of goods or strategic services to combat the pandemic.
“Renowned institutes and laboratories have confirmed the effectiveness of our technology. It is therefore extremely consistent that the Ile-de-France region, in which we have our headquarters and our R&D laboratory and where we will continue to invest heavily, develop our innovative air – Promotes decontamination technology. COVID-19 has become a global challenge. We are honored and honored that our region has selected us to further improve the contribution of air purification in the fight against the coronavirus and to ensure that that the health of our society is guaranteed in the long term, “says Alain Hachet, CEO of Calistair.
The funds made available will be used on the one hand to expand the production of the chemical catalyst invented by Calistair in a state-of-the-art plant in Vaux-le-Penil (Seine-et-Marne) and, on the other hand, to develop and produce reactor modules that are used in RLT / air conditioning systems can be retrofitted.
Developed by Dr. Jerome Taranto, the founder of Calistair, uses the patented Calistair Technology to destroy highly effective volatile organic compounds, such as toxic aldehydes, microorganisms, fungi, bacteria and viruses and even the corona virus.
The Calistair Technology, developed in France, is already in use in more than 80 hospitals and laboratories in France and also in many clinics and health facilities in Switzerland, Scandinavia and Germany
The French Calistair SAS is one of the leading providers of air decontamination technologies for hospitals in France. The German headquarters are in Frankfurt am Main. Calistair Technology removes dreaded viruses, bacteria, fungi and other allergens, as well as volatile organic compounds such as toxic aldehydes, gases and odors from the room air. Calistair’s professional solutions meet the requirements for the decontamination and destruction of particulate, microbiological and chemical pollutants in accordance with the EN 1886 and NF B44-200 standards and allow compliance with the ISO 14644 and NF S90-351 standards for highly effective air purification for clean rooms, controlled Environments and sensitive living areas. With the new C300, Calistair now also enables private customers to enjoy the benefits of clinically pure air.
Contact
Calistair GmbH
Alain Hachet
Clemensstr. 9
60487 Frankfurt am Main
030-44318088
[email protected]
https://calistair-c300.com
(Those: https://calistair-c300.com)
More news from Calistair GmbH
Matching messages and messages
–
TAGs
Calistair, air purification, corona, air purifier, decontamination, Covid-19, virus, coronavirus, SARS-CoV-2, RLT, system, award, study
Suitable providers
fitting products
– .
